经导管主动脉瓣植入术后再入院的发生率与预测因素
基于Bern TAVI注册2007年8月至2014年6月出院存活的868例患者,1年内221例(25.4%)再入院。男性与3期肾损伤为任何再入院的独立危险因素,既往心肌梗死与院内致命性出血与心血管再入院相关;再入院后死亡率事件率显著升高(RR 4.29)。
要点
- TAVI出院存活患者1年内再入院率为25.4%(221/868)。
- 男性(SHR 1.33)与3期肾损伤(SHR 2.04)为任何再入院的独立危险因素。
- 任何原因再入院后死亡事件率显著升高(RR 4.29,95%CI 2.86-6.42)。
核心结论
- TAVI后第一年内每4例患者中约1例发生再入院,再入院与死亡率显著升高相关。
研究设计与样本
- 分析Bern TAVI注册2007年8月至2014年6月纳入的患者,出院存活868例,采用Fine和Gray竞争风险回归识别1年内再入院的预测因素并以bootstrap进行内部验证。
主要发现
- 868例出院存活患者中221例(25.4%)在1年内再入院;308次再入院中46.1%为心血管原因,其中心力衰竭最常见。
- 非心血管再入院原因包括外科手术11.7%、胃肠道疾病9.7%、恶性肿瘤4.9%、呼吸系统疾病4.6%和慢性肾衰竭2.6%。
- 再入院患者较未再入院患者更常见男性、心房颤动及更高的肌酐值(所有情况P < 0.05)。
- 任何再入院的独立危险因素为男性(SHR 1.33,95%CI 1.02-1.73,P = 0.035)和3期肾损伤(SHR 2.04,95%CI 1.12-3.71,P = 0.021)。
- 心血管再入院的关联因素为既往心肌梗死(SHR 1.88,95%CI 1.22-2.90,P = 0.004)和院内致命性出血(SHR 2.18,95%CI 1.24-3.85,P = 0.007);任何原因再入院后死亡事件率显著升高(RR 4.29,95%CI 2.86-6.42,P < 0.001)。
关键数值与推荐
- 任何再入院的独立危险因素:男性SHR 1.33(95%CI 1.02-1.73,P = 0.035),3期肾损伤SHR 2.04(95%CI 1.12-3.71,P = 0.021)。
- 心血管再入院的关联因素:既往心肌梗死SHR 1.88(95%CI 1.22-2.90,P = 0.004),院内致命性出血SHR 2.18(95%CI 1.24-3.85,P = 0.007)。
- 任何原因再入院后死亡事件率:RR 4.29(95%CI 2.86-6.42,P < 0.001)。
临床怎么用
- 原文未报告。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To analyse reasons, timing and predictors of hospital readmissions after transcatheter aortic valve implantation (TAVI). METHODS AND RESULTS: Patients included in the Bern TAVI Registry between August 2007 and June 2014 were analysed. Fine and Gray competing risk regression was used to identify factors predictive of hospital readmission within 1 year after TAVI with bootstrap analysis for internal validation. Of 868 patients alive at discharge, 221 (25.4%) were readmitted within 1 year. Compared with patients not requiring readmission, those with at least one readmission more frequently were male and more often had atrial fibrillation and higher creatinine values (P < 0.05 for all cases). For overall 308 readmissions, cardiovascular causes accounted for 46.1% with heart failure as the most frequent indication; non-cardiovascular readmissions occurred for surgery (11.7%), gastrointestinal disorders (9.7%), malignancy (4.9%), respiratory diseases (4.6%) and chronic kidney failure (2.6%). Male gender (subhazard ratio, SHR, 1.33, 95% confidence intervals, CI, 1.02-1.73, P = 0.035) and stage 3 kidney injury (SHR 2.04, 95% CI 1.12-3.71, P = 0.021) were found independent risk factors for any hospital readmission, whereas previous myocardial infarction (SHR 1.88, 95% CI 1.22-2.90, P = 0.004) and in-hospital life-threatening bleeding (SHR 2.18, 95%CI 1.24-3.85, P = 0.007) were associated with cardiovascular readmissions. The event rate for mortality was significantly increased after readmissions for any cause (RR 4.29, 95% CI 2.86-6.42, P < 0.001). CONCLUSION: Hospital readmission was observed in one out of four patients during the first year after TAVI and was associated with a significant increase in mortality.
引用
- Franzone A, Pilgrim T, Arnold N, et al. Rates and predictors of hospital readmission after transcatheter aortic valve implantation. Eur Heart J. 2017. PMID: 28430920. doi:10.1093/eurheartj/ehx182
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。